Sosum Hard — Highest-Density LTSR HA Filler for Structural Sculpting (2 x 1ml)
Sosum Hard is JSBIO’s structural-grade variant — 20 mg/mL cross-linked HA via patented LTSR technology with the most pronounced cross-linking density in the Sosum range. Lidocaine-free formulation. Engineered for deep subcutaneous and supraperiosteal placement: chin projection, jawline angle definition, structural facial sculpting. 12-18 months durability with minimal migration.
Manufacturer: JSBIO Co. Ltd., South Korea · Established 2013
How Sosum Hard Highest Density Dermal Filler Is Engineered
Low-Temperature Stabilization Reaction Technology
JSBIO Co. Ltd.’s proprietary cross-linking process produces a stabilised HA gel matrix engineered for sustained tissue retention. The technology balances viscoelasticity (firmness for projection) with extrusion smoothness (easier injection through the 25G needle). The result: predictable handling, consistent gel distribution, and 12-18 months durability in deep subcutaneous placement.
Quality & Purity
Non-animal hyaluronic acid produced by bacterial fermentation. Endotoxin levels controlled below international safety thresholds. Stringent manufacturing under GMP-certified conditions minimises BDDE residue, heavy metals, and protein contaminants — reducing the risk of post-injection inflammation, granuloma formation, or hypersensitivity reactions in suitable patient profiles.
Sosum Hard Highest Density Dermal Filler Active Ingredients
Cross-Linked Hyaluronic Acid
Non-animal hyaluronic acid produced by bacterial fermentation, cross-linked using JSBIO Co. Ltd.’s Low-Temperature Stabilization Reaction Technology technology. The cross-linking process creates a stable, durable gel matrix that resists rapid enzymatic breakdown in tissue. Phosphate-buffered saline carries the gel at near-physiological pH.
Lidocaine HCl
Premixed local anaesthetic at the industry-standard 0.3% concentration. Reduces injection-site discomfort and eliminates the need for on-site mixing with separate lidocaine vials. The lidocaine itself wears off within hours of injection and does not affect long-term gel duration.
Where Sosum Hard Highest Density Dermal Filler Is Used
Chin Projection
Primary indication. Supraperiosteal placement for non-surgical chin augmentation and profile enhancement.
Mandibular Angle Definition
Gonial angle enhancement for face shape modification.
Deep Cheek Augmentation
Subcutaneous and supraperiosteal cheek volumising for sustained projection.
Structural Facial Sculpting
Multi-zone deep contouring including lateral face. The high cohesion minimises migration.
Sosum Hard Highest Density Dermal Filler vs Juvederm vs Restylane
| Feature | Sosum | Juvederm (Allergan) | Restylane (Galderma) |
|---|---|---|---|
| HA Concentration | 20 mg/mL | 15–24 mg/mL | 20 mg/mL |
| Cross-Linking Tech | LTSR | Vycross / Hylacross | NASHA® / OBT |
| Lidocaine | 0.3% (premixed) | 0.3% (XC lines) | 0.3% (Lidocaine variants) |
| Duration | 12-18 months | 6–24 months (varies) | 6–18 months (varies) |
| Origin | South Korea (JSBIO Co. Ltd.) | USA (Allergan / AbbVie) | Sweden (Galderma) |
| Established Since | 2013 | 2006 | 1996 |
↔ Swipe horizontally on mobile to view all columns
Comparison based on manufacturer published data. See our top dermal filler comparison guide for broader market context.
Sosum Hard Highest Density Dermal Filler Product Specifications
Manufacturer
- Brand: Sosum
- Company: JSBIO Co. Ltd.
- Country: South Korea
- Established: 2013
Formula
- HA Source: Non-animal bacterial fermentation
- HA Concentration: 20 mg/mL
- Lidocaine: 0.3% (3 mg/mL) premixed
- Cross-linking: Low-Temperature Stabilization Reaction Technology
Performance
- Duration: 12-18 months
- Injection Depth: Deep subcutaneous · supraperiosteal
- Recommended Needle: 25G
- Last Reviewed: May 2026
Approval & Storage
- Approvals: MFDS approval 2013 · CE certified · GMP
- Packaging: 2 x 1 mL syringes + needles
- Storage: 2–25 °C, do not freeze
- Shelf life: 24 months unopened
Verify regulatory status at the official Korean MFDS database — nedrug.mfds.go.kr. For market pricing context, see our dermal filler pricing guide.
Sosum Hard Highest Density Dermal Filler — Frequently Asked Questions
What is Sosum Hard Highest Density Dermal Filler?
Sosum Hard is JSBIO’s structural-grade variant — 20 mg/mL cross-linked HA via patented LTSR technology with the most pronounced cross-linking density in the Sosum range. Lidocaine-free formulation. Engineered for deep subcutaneous and supraperiosteal placement: chin projection, jawline angle definition, structural facial sculpting. 12-18 months durability with minimal migration.
Where is Sosum Hard Highest Density Dermal Filler manufactured?
Sosum Hard Highest Density Dermal Filler is manufactured by JSBIO Co. Ltd., a South Korea-based medical device and pharmaceutical company established in 2013. The product is part of the Sosum dermal filler range, which is distributed across multiple international markets. Regulatory status: MFDS approval 2013 · CE certified · GMP.
What is the HA concentration in Sosum Hard Highest Density Dermal Filler?
Sosum Hard Highest Density Dermal Filler contains 20 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using JSBIO Co. Ltd.’s Low-Temperature Stabilization Reaction Technology technology. Phosphate-buffered saline at near-physiological pH carries the gel.
How long do Sosum Hard Highest Density Dermal Filler results last?
Per JSBIO Co. Ltd.’s clinical data, Sosum Hard Highest Density Dermal Filler delivers 12-18 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Deep subcutaneous placement typically delivers the longer end of the duration range.
What is the recommended injection depth for Sosum Hard Highest Density Dermal Filler?
Sosum Hard Highest Density Dermal Filler is engineered for deep subcutaneous · supraperiosteal placement. The standard recommended needle is 25G, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.
Is Sosum Hard Highest Density Dermal Filler FDA approved or CE marked?
Sosum Hard Highest Density Dermal Filler regulatory status: MFDS approval 2013 · CE certified · GMP. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.
How should Sosum Hard Highest Density Dermal Filler be stored at the clinic?
Store Sosum Hard Highest Density Dermal Filler between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.
Does Sosum Hard Highest Density Dermal Filler contain animal-derived ingredients?
No. Sosum Hard Highest Density Dermal Filler uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).
Can Sosum Hard Highest Density Dermal Filler be combined with other dermal fillers in the same session?
Yes — layered protocols combining different fillers are standard aesthetic practice. Sosum Hard Highest Density Dermal Filler can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.
What’s the difference between Sosum H and Sosum Hard?
Both are deep-contouring Sosum variants with 20 mg/mL HA via LTSR cross-linking, lidocaine-free. They differ in cross-linking density and intended placement layer. Sosum H is positioned for deep dermal-to-subcutaneous placement (jawline, cheek augmentation, liquid rhinoplasty, deep folds). Sosum Hard has the most pronounced cross-linking — positioned for deep subcutaneous and supraperiosteal placement (chin projection, mandibular angle, structural sculpting). Practitioners select H for combined deep-dermal-and-subcutaneous protocols; Hard for the deepest, most structural placements.
Other HA Dermal Fillers on Fillersfairy
Sosum S Fine Lines Dermal Filler
Sosum S is JSBIO’s lightest variant — 20 mg/mL cross-linked HA produced via patented LTSR (Low-Temperature Stabilization Reacti…
View product →Sosum M Moderate Wrinkles Dermal Filler
Sosum M is JSBIO’s medium-density variant — 20 mg/mL cross-linked HA via patented LTSR technology with G’ >250Pa. Lidocaine-fre…
View product →Juvederm Ultra 2 with Lidocaine (2 x 0.55ml)
Juvederm Ultra 2 is Allergan’s lightest Hylacross-technology filler — 24 mg/mL cross-linked non-animal hyaluronic acid + 0.3% l…
View product →All Dermal Fillers
Browse our full range of HA dermal fillers, lip fillers, body fillers, and skin boosters for facial volume, contouring, and rejuvenation.
Browse category →Read Before Clinical Use
Sosum Hard Highest Density Dermal Filler is a prescription medical device for use only by licensed aesthetic practitioners. Common reactions include injection-site bruising, swelling, redness, and tenderness — generally resolving within days. Deep placement (subcutaneous and supraperiosteal layers) involves heightened anatomical awareness of facial vasculature; practitioners require access to hyaluronidase for emergency dissolution. Like all hyaluronic acid dermal fillers, treatment carries rare but serious vascular complication risks. Contraindicated in patients with known hypersensitivity to hyaluronic acid or lidocaine, active skin infection at the treatment site, pregnancy, or breastfeeding. Full contraindications, vascular complication protocols, aftercare, and emergency guidance are detailed on the dermal filler safety page.
Read Full Dermal Filler Safety Information →Sosum is a registered trademark of JSBIO Co. Ltd.. Fillersfairy.com is a channel distributor and does not provide medical advice. This page is for informational purposes only and does not replace the manufacturer’s official Instructions for Use, which remains the authoritative source for clinical administration. Regulatory status varies by jurisdiction — buyers are responsible for verifying legal status before ordering. Last reviewed May 2026 against JSBIO Co. Ltd. manufacturer documentation.


Reviews
There are no reviews yet.